Lv1
58 积分 2024-01-29 加入
In vivo chimeric antigen receptor (CAR)-T cell therapy
6个月前
已完结
In vivo CAR engineering for immunotherapy
6个月前
已完结
Effects of administration of an anti-CD5 plus immunoconjugate in rheumatoid arthritis. Results of two phase II studies. The CD5 Plus Rheumatoid Arthritis Investigators Group
8个月前
已完结
Engineering innate immune cells for cancer immunotherapy
9个月前
已完结
皖公网安备34019202002308
